Apr 22, 2019
InvestorPlace: Intuitive Surgical Stock Is the Best MedTech Company to Buy and Hold Intuitive Surgical (NASDAQ:ISRG) stock has started off 2019 in great fashion with back-to-back FDA approvals.
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from Singapore
seen from United Kingdom
seen from United States
seen from Italy
seen from Türkiye
seen from Malaysia
seen from United States
seen from United States
seen from Ghana
seen from United States
seen from China
seen from Russia
seen from United States
seen from United States
seen from Malaysia
InvestorPlace: Intuitive Surgical Stock Is the Best MedTech Company to Buy and Hold Intuitive Surgical (NASDAQ:ISRG) stock has started off 2019 in great fashion with back-to-back FDA approvals.
Medtronic PLC (NYSE:MDT)’s Robotic Surgery Partner Mazor Releases Studies Advocating The Effectiveness Of Its Machine
Mazor Robotics, a partner of Medtronic Plc (NYSE:MDT)’s in surgical robotic has released findings from two studies on the effectiveness of its guidance platform in spinal surgeries versus freehand minimally invasive surgery. The results have shown that Mazor’s machines reduce the rates of complications and revision surgical procedure. The studies were presentedat the 23rd International Meeting on Advanced Spine Techniques in Washington, DC.
The first study indicated a three time higher rate of complication in both open freehand cases and freehanded minimally invasive surgery, compared to procedures that used Mazor’s Renaissance robotic spinal surgery system. Surgical revision rate was about 3.8 times higher in freehand cases than in the Renaissance cases. In the second study that had been released in May, data indicated that using Mazor’s guidance system had significantly reduced complication and revision rates as compared to traditional freehand surgery cases.
Speaking at the event OriHadomi, Mazor’s CEO, noted that while MIS adoption in the spinal surgeries is improving, the rate of which MIS surgeries are using Mazor’s surgical guidance technology is far higher than the industry average. This is a demonstration that Mazor’s technology can deliver abetter outcome to patients. Dr. Sweeney, one of the lead investigators of the retrospective study noted that the large retrospectivedataset corroborates the primary findings of the prospective, thus validating the use of Mazor’s Robotics guidance technologies in minimally invasive surgery.
Medtronic’s ventured into the growing field of spinal surgical robotics earlier in the year, following a partnership with Israel’s Mazor. Under the terms of the agreement, the deal could surpass $50 million if all the three tranches are exercised. Medtronic could end up holding about 15% of Mazor.
Medtronic’s joined a growing number of players in the surgical robotics field. Some include Johnson & Johnson (NYSE:JNJ) and Verily’s joint venture and Intuitive Surgical, Inc. (NASDAQ:ISRG) among others.
Medtronic PLC (NYSE:MDT)’s Robotic Surgery Partner Mazor Releases Studies Advocating The Effectiveness Of Its Machine was originally published on Market Exclusive
Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line
Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line
Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line
View On WordPress
CalAmp Announces Multi-Carrier Availability on 4G LTE Cellular Router for Fixed and Mobile Industrial Applications
CalAmp Announces Multi-Carrier Availability on 4G LTE Cellular Router for Fixed and Mobile Industrial Applications
CalAmp Announces Multi-Carrier Availability on 4G LTE Cellular Router for Fixed and Mobile Industrial Applications
View On WordPress
Hansen Medical(R) to Demonstrate New Magellan(TM) Robotic Catheter eKit and Present Magellan Robotic System at 41st Annual Society of Interventional Radiology (SIR) Scientific Meeting
Hansen Medical(R) to Demonstrate New Magellan(TM) Robotic Catheter eKit and Present Magellan Robotic System at 41st Annual Society of Interventional Radiology (SIR) Scientific Meeting
MOUNTAIN VIEW, CA–(Marketwired – Mar 17, 2016) – Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the Annual Society of Interventional Radiology (SIR) Scientific Meeting April 2-7 in Vancouver, British Columbia, Canada. The Company will showcase the newly approved Magellan Robotic Catheter eKit that…
View On WordPress
Hansen Medical(R) Announces First Clinical Procedure in the US With New Magellan(TM) Robotic Catheter eKit
Hansen Medical(R) Announces First Clinical Procedure in the US With New Magellan(TM) Robotic Catheter eKit
Hansen Medical(R) Announces First Clinical Procedure in the US With New Magellan(TM) Robotic Catheter eKit
View On WordPress
CalAmp Commences Tender Offer for All Outstanding Shares of LoJack
CalAmp Commences Tender Offer for All Outstanding Shares of LoJack
OXNARD, CA and CANTON, MA–(Marketwired – Feb 16, 2016) – CalAmp Corp. (NASDAQ: CAMP) (“CalAmp”) and LoJack Corporation (NASDAQ: LOJN) (“LoJack”) today announced that CalAmp’s wholly-owned subsidiary, Lexus Acquisition Sub, Inc. (“Purchaser”), is commencing a cash tender offer to purchase all outstanding shares of LoJack. CalAmp and LoJack previously announced on Monday, February 1, 2016 that they…
View On WordPress
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
View On WordPress